Dengue Manuscript Final

  • Upload
    pb

  • View
    221

  • Download
    0

Embed Size (px)

Citation preview

  • 8/12/2019 Dengue Manuscript Final

    1/16

    Objectives

    To be able to gain knowledge and understanding about the disease process

    of dengue, its classification and its prevention and management.

    SCOPE OF PRESENTATION

    Definition of terms

    Alternative Names

    Etiologic Agent

    Mode of Transmission

    Epidemiology

    ources of infection

    !ncidence

    !ncubation "eriod and "eriod of #ommunicability

    Disease "rocess of Dengue

    Dengue #ase #lassification

    "hases of Dengue illness

    $aboratory E%aminations

    "revention, Management,Treatment and #ontrol

    Nursing !nterventions

    "rognosis

    #heck on $earning

    ummary

    1

  • 8/12/2019 Dengue Manuscript Final

    2/16

    DEFINITION OF TERMS

    Defervescence& Abatement of a fever as indicated by a reduction in body

    temperature

    DENV& dengue virus

    Epidemiolo!' deals with transmission and control of the disease.

    Etioloic "ent& it includes viruses, fungi, proto(oa, bacteria

    Incidence' the number of cases of the disease

    Inc#b"tion Period & The period between infection and the appearance of

    symptoms of the disease

    Mode of Tr"nsmission ' it indicates the potential of the disease)

    conveyance of the agent to the host

    Pronosis&A prediction of the course of a disease

    Reservoir' the environment in which the agent is found

    Vector' any agent that carries a disease

    DEN$%E

    An infectious disease caused by any of the four serotypes of flavivirus

    *DEN+,DEN+-,DEN+,DEN+/0 which are spread by mos1uitoes in tropicaland subtropical areas.

    #haracteri(ed by severe pain behind the eye and in the 2oints and bones and

    accompanied by an initial erythema and a terminal rash.

    A&TERNATIVE NAMES

    3reakbone 4ever

    2

  • 8/12/2019 Dengue Manuscript Final

    3/16

    Dandy 4ever

    "hilippine 5emorrhagic 4eve

    ETIO&O$IC A$ENT

    4lavivirus * DEN+ , - , , /0

    Arbovirus namely 6nyong&onyong, #hikungunya, 7est Nile

    MODE OF TRANSMISSION

    3ite of infective mos1uitoes principally femaleAedes aegypti (urban areas)

    and Aedes albopictus (rural areas).

    Described as8

    Day biting, low flying mos1uito with increased biting activity for two

    hours after sunrise and two hours before sunset

    3reeds on clear, stagnant water

    5as gray wings and white stripes on the body

    Aedes "e!pti

    3

  • 8/12/2019 Dengue Manuscript Final

    4/16

    EPIDEMIO&O$'

    Dengue is the most rapidly spreading mos1uito&borne viral disease in the

    world. !n the last 9: years, incidence has increased :&fold with increasing

    geographic e%pansion to new countries and in the present decade from urban

    to rural settings.

    An estimated 9: million dengue infections occur annually and appro%imately

    -.9 billion people live in dengue endemic countries.

    3etween -:: and -::;, ,:-:, cases were reported in #ambodia,

    Malaysia, "hilippines and +ietnam& the four countries in the 7estern "acific

    ; *official country reports0. #ompared with

    other countries in the same region, the number of cases and deaths remained

    highest in #ambodia and the "hilippines in -::;. 6verall, case management

    has improved in the 7estern "acific

  • 8/12/2019 Dengue Manuscript Final

    5/16

    AE8 The infection may occur at any age but common among school

    children with the peak between / and B years old

    EC8 3oth se%es e1ually affected

    EA6N8 More fre1uent during rainy season or months

    E6

  • 8/12/2019 Dengue Manuscript Final

    6/16

    ;&- days on the salivary gland

    of the mos1uito

    "ortal of Entry in the kin

    * Mos1uito 3ite 0

    +irus in the blood stimulates the release

    of the 73#s including 3 lymphocytes

    Antibodies attach to viral antigen and

    Performs phagocytosis and dengue

    virus replication

  • 8/12/2019 Dengue Manuscript Final

    7/16

    #oagulation defect Thrombocytopenia

    3leeding !ncreased

    +ascular

    "ermeability

    5emoconcentration $eakage of "lasma

    "leural Effusion

    5ypotension

    hock

    DEAT5

    DEN$%E CASE C&ASSIFICATION ACCORDIN$ TO *)O

    FM"T6MAT!# DENE +! rade !

    7

  • 8/12/2019 Dengue Manuscript Final

    8/16

    rade !!

    rade !!! Dengue hock yndrome

    rade !+

    #urrently the classification into DF/DHF/DSScontinues to be widely used.

    Dengue 4ever ' the type without significant hemorrhages

    Dengue 5emorrhagic 4ever ' characteri(ed by abnormal vascular

    permeability, hypovolemia, and abnormal blood clotting

    mechanism.

    $r"de I' 4ever accompanied by non&specific constitutional

    symptoms and the only hemorrhagic manifestation is *G0positive

    tourni1uet test.

    $r"de II' All signs of grade ! plus spontaneous bleeding from thenose, gums, !T.

    $r"de III' "resence of circulatory failure as manifested by weak

    pulse, narrow pulse pressure, hypotension, cold clammy skin and

    restlessness.

    $r"de IV' "rofound shock) undetectable blood pressure and pulse

    8

  • 8/12/2019 Dengue Manuscript Final

    9/16

    + P)ASES OF DEN$%E I&&NESS

    I, FE(RI&E

    $ast -&= days

    5igh&grade fever

    4acial flushing

    kin erythema

    enerali(ed body ache

    9

  • 8/12/2019 Dengue Manuscript Final

    10/16

    5eadache

    Anore%ia

    Nausea and vomiting

    *G0 positive tourni1uet test

    "etechiae and mucosal membrane bleeding *e.g. nose and gums0

    Decreased in total white cell count

    Enlarged and tender liver

    5ermans sign * pathognomonic sign0 maculopapular or petechial rash

    maybe present that usually start in the distal proportion of the

    e%tremities) the skin appear purple with blanched areas with varied

    si(es

    II,CRITICA&

    Time of defervescence *temperature drops to =.9&;H#0 on days &= of

    illness

    I capillary permeability)I hematocrit level *marks the beginning of critical

    phase0

    "rogressive leukopenia)J platelet count

    "leural effusion and ascites *seen in chest %&ray and abdominal ultrasound0

    hock when critical volume of plasma is lost through leakage)preceded by

    warning signs * subnormal body temperature0

    The conse1uent organ perfusion results in progressive organ

    impairment,metabolic acidosis and disseminated intravascular coagulation

    which leads to hemorrhage causing J hematocrit in severe shock. !ncreased

    total white cell count in patients with severe bleeding.

    !mprovement after defervescence said to have non severe dengue and

    some progress to critical phase without defervescence.

    Those who deteriorate with warning signs are called dengue with warning

    signs.

    III, RECOVER'

    "atient survives the -/&/; critical phase, a gradual reabsorption of

    e%travascular compartment fluid takes place in the following /;&=- hours.

    10

  • 8/12/2019 Dengue Manuscript Final

    11/16

    !mprovement on general well being, appetite returns and gastrointestinal

    symptoms abate

    tabili(ed hematocrit or may be lower due to dilutional effect of reabsorbed

    fluid

    SEVERE DEN$%E

    Defined as one or more of the following8

    "lasma leakage that may lead to shock *dengue shock0 and or fluid

    accumulation with or without respiratory distress

    evere bleeding

    evere organ impairment

    During the initial stage of shock, the compensatory mechanism which

    maintains a normal systolic blood pressure produces tachycardia and

    peripheral vasoconstriction

    "ulse pressure of -:mm5g or less and rapid weak pulse or hypotension

    5igh or progressively rising hematocrit "leural effusion or ascites

    #irculatory compromise or shock * tachycardia, cold and clammy e%tremities 0

    #apillary refill time greater than secs.

    7eak or undetectable pulse or in late shock ) unrecordable blood pressure

    ignificant bleeding

    Altered level of consciousness

    11

  • 8/12/2019 Dengue Manuscript Final

    12/16

    &A(ORATOR' E-AMINATIONS

    Test may include the following8

    5ematocrit , "latelet count

    Electrolytes

    #oagulation studies

    $iver en(ymes

    Torni1uet test

    C&ray of the chest *may demonstrate pleural effusion0

    erologic studies *demonstrate antibodies to Dengue viruses0

    erum studies from samples taken during acute illness and

    convalescence *5igh in titer to Dengue antigen0

    PREVENTION AND CONTRO&

    Early detection and treatment of cases

    #ase finding and reporting

    5ealth teaching

    !solation of patient *se of mos1uito nets0

    Destroy the breeding places

    a. #hanging water and srubbing sides of lower vases once a week

    b. Destroy breeding places of mos1uito by cleaning surroundings, proper

    disposal of rubber tires, empty bottles and cans

    c. Avoid too many hanging clothes inside the house

    d.

  • 8/12/2019 Dengue Manuscript Final

    13/16

    TREATMENT

    Mainly symptomatic and supportive

    There are no specific antiviral drugs

    I,DEN$%E )EMORR)A$IC FEVER .*IT)O%T S)OC/0

    6ral fluid and electrolyte ' should be encouraged to prevent and correct

    dehydration which results from hyperpyre%ia, anore%ia and vomiting.

    Anti& pyretics Kacetaminophen *do not use aspirin0

    Anti& convulsant drugs *i.e dilantin0

    5ematocrit *5ct0 determination

    5emoglobin *5gt0 determination

    "atients should be hospitali(ed and treated immediately when signs and

    symptoms of shock are noted.

    II, DEN$%E S)OC/ S'NDROME

    3lood transfusion

    !ndicated when significant signs of bleeding as melena and

    hematemesis

    7hen thrombocytopenia sets in *platelet count L 9:,:::Kmm 0

    "repare fresh whole blood

    Transfuse if active bleeding occurs or both 5ct and 5gb level falls

    "ersistent bleeding and disseminated intravascular coagulopathy

    follow whole blood transfusion with cryoprecipitate

    6%ygen

    !ndicated for all patients in shock

    edatives

    May be needed to allay apprehension or agitation

    N%RSIN$ INTERVENTIONS

    #ontrol measure8 eradication of mos1uitoes

    4or5emorrhage '

    13

  • 8/12/2019 Dengue Manuscript Final

    14/16

    a. eep the patient at rest during bleeding episodes.

    b. 4or nose bleeding, maintain an elevated position of trunk and put an ice

    bag over the forehead. 4or melena, ice bag over the abdomen.

    c. !f transfusion is given, support the patient during the therapy. 6bserve

    signs of deterioration *shock0 such as low pulse, cold clammy skin.

    hock

    a. "revention is the best treatment

    b. Trendelenburg position facilitates greater blood volume to the head part

    4or an%iety of "atient and 4amily&e%plain thoroughly the nature, discomforts

    and limitations of activity associated with diagnostic procedures

    Diet

    a. $ow fat, low fiber, non&irritating, non&carbonated and avoid dark colored

    foods

    4ever

    a. #ooling measures through sponges and administer prescribed drugs.

    b. Encouraged fluid intake unless contraindicated

    PRO$NOSIS

  • 8/12/2019 Dengue Manuscript Final

    15/16

    $aboratory E%aminations

    "revention and #ontrol

    Treatment and Nursing !nterventions

    "rognosis

    REFERENCES

    #ommunity 5ealth Nursing ervices in the "hilippines, Department of 5ealth

    >thEdition, -:::

    Mims Medical Microbiology /thEdition -::;

    #ompilation of #ommunicable Diseases in Nursing

    Abraham . 3enenson, O #ontrol of #ommunicable Diseases in Man 9th

    Edition >>:

    *ebsites1

    #enters for Disease #ontrol and "revention www.cdc.gov

    7orld 5ealth 6rgani(ation www.who.int

    7ikipedia The 4ree Encyclopedia http8KKen.wikipedia.orgKwikiKDenguefever

    15

    http://www.cdc.gov/http://www.who.int/http://en.wikipedia.org/wiki/Denguefeverhttp://www.cdc.gov/http://www.who.int/http://en.wikipedia.org/wiki/Denguefever
  • 8/12/2019 Dengue Manuscript Final

    16/16

    16